MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Michels, G.
Right arrow Articles by Herzig, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Michels, G.
Right arrow Articles by Herzig, S.

Vol. 61, Issue 3, 682-694, March 2002

Single-Channel Pharmacology of Mibefradil in Human Native T-Type and Recombinant Cav3.2 Calcium Channels

Guido Michels, Jan Matthes, Renate Handrock, Ute Kuchinke, Ferdi Groner, Leanne L. Cribbs, Alexey Pereverzev, Toni Schneider, Edward Perez-Reyes, and Stefan Herzig

Departments of Pharmacology (G.M., J.M., R.H., U.K., F.G., S.H.) and Neurophysiology (A.P., T.S.), University of Cologne, Cologne, Germany; Department of Medicine, Cardiovascular Institute, Loyola University, Maywood, Illinois (L.L.C.); and Department of Pharmacology, University of Virginia, Charlottesville, Virginia (E.P-R.)

To study the molecular pharmacology of low-voltage-activated calcium channels in biophysical detail, human medullary thyroid carcinoma (hMTC) cells were investigated using the single-channel technique. These cells had been reported to express T-type whole-cell currents and a Cav3.2 (or alpha 1H) channel subunit. We observed two types of single-channel activity that were easily distinguished based on single-channel conductance, voltage dependence of activation, time course of inactivation, rapid gating kinetics, and the response to the calcium agonist (S)-Bay K 8644. Type II channels had biophysical properties (activation, inactivation, conductance) typical for high-voltage-activated calcium channels. They were markedly stimulated by 1 µM (S)-Bay K 8644, allowing to identify them as L-type channels. The channel termed type I is a low-voltage-activated, small-conductance (7.2 pS) channel that inactivates rapidly and is not modulated by (S)-Bay K 8644. Type I channels are therefore classified as T-type channels. They were strongly inhibited by 10 µM mibefradil. Mibefradil block was caused by changes in two gating parameters: a pronounced reduction in fraction of active sweeps and a slight shortening of the open-state duration. Single recombinant low-voltage-activated T-type calcium channels were studied in comparison, using human embryonic kidney 293 cells overexpressing the pore-forming Cav3.2 subunit. Along all criteria examined (mechanisms of block, extent of block), recombinant Cav3.2 interact with mibefradil in the same way as their native counterparts expressed in hMTC cells. In conclusion, the pharmacologic phenotype of these native human T-type channels---as probed by mibefradil---is similar to recombinant human Cav3.2.


Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Physiol.Home page
Z. Lin, K. Witschas, T. Garcia, R.-S. Chen, J. P. Hansen, Z. M. Sellers, E. Kuzmenkina, S. Herzig, and P. M. Best
A critical GxxxA motif in the {gamma}6 calcium channel subunit mediates its inhibitory effect on Cav3.1 calcium current
J. Physiol., November 15, 2008; 586(22): 5349 - 5366.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S. Herzig, I. F. Y. Khan, D. Grundemann, J. Matthes, A. Ludwig, G. Michels, U. C. Hoppe, D. Chaudhuri, A. Schwartz, D. T. Yue, et al.
Mechanism of Cav1.2 channel modulation by the amino terminus of cardiac {beta}2-subunits
FASEB J, May 1, 2007; 21(7): 1527 - 1538.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. Michels, F. Er, M. Eicks, S. Herzig, and U. C. Hoppe
Long-Term and Immediate Effect of Testosterone on Single T-Type Calcium Channel in Neonatal Rat Cardiomyocytes
Endocrinology, November 1, 2006; 147(11): 5160 - 5169.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. I. Brueggemann, B. L. Martin, J. Barakat, K. L. Byron, and L. L. Cribbs
Low voltage-activated calcium channels in vascular smooth muscle: T-type channels and AVP-stimulated calcium spiking
Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H923 - H935.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. Michels, F. Er, I. Khan, M. Sudkamp, S. Herzig, and U. C. Hoppe
Single-Channel Properties Support a Potential Contribution of Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels and If to Cardiac Arrhythmias
Circulation, February 1, 2005; 111(4): 399 - 404.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. M. McNulty and D. A. Hanck
State-Dependent Mibefradil Block of Na+ Channels
Mol. Pharmacol., December 1, 2004; 66(6): 1652 - 1661.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Foerster, F. Groner, J. Matthes, W. J. Koch, L. Birnbaumer, and S. Herzig
Cardioprotection specific for the G protein Gi2 in chronic adrenergic signaling through {beta}2-adrenoceptors
PNAS, November 25, 2003; 100(24): 14475 - 14480.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
G. Pinato and J. Midtgaard
Regulation of Granule Cell Excitability by a Low-Threshold Calcium Spike in Turtle Olfactory Bulb
J Neurophysiol, November 1, 2003; 90(5): 3341 - 3351.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
E. Perez-Reyes
Molecular Physiology of Low-Voltage-Activated T-type Calcium Channels
Physiol Rev, January 1, 2003; 83(1): 117 - 161.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics